Earnings History Data for AVEO Pharmaceuticals (AVEO) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.

AVEO Pharmaceuticals

AVEO Pharmaceuticals, Inc. is a biopharmaceutical company engaged in discovering, developing and commercializing novel cancer therapeutics. Its product candidates are targeted against important mechanisms known or believed to be involved in cancer. Tivozanib, the Company's lead product candidate, is a highly potent and selective oral inhibitor of the vascular endothelial growth factor, or VEGF, receptors 1, 2 and 3. In addition to tivozanib, AVEO Pharmaceuticals has a pipeline of monoclonal antibodies derived from Human Response Platform (HRP), a novel method of building preclinical models of human cancer, which are intended to more accurately represent cancer biology in patients. AV-299 is the Company's next product candidate which is an antibody that binds to hepatocyte growth factor, or HGF, thereby blocking its function. AVEO Pharmaceuticals, Inc. is based in Cambridge, Massachusetts.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
07-11-2022 AH 4:05 PM ET
(Nov 7)		 AVEO AVEO Pharmaceuticals 513.00 -0.09 -0.16 0.00 AVEO Pharmaceuticals GAAP EPS of -$0.09 beats by $0.08, revenue of $30.4M beats by $0.54M
[11/7/2022 4:52 PM]		 14.78 0.0 
(0.00%)		 14.78 0.0 
(0.00%)		 3.06 - 14.95 1,185,562 1,530,000 1,302
04-08-2022 PM 4:05 PM ET
(Aug 4)		 AVEO AVEO Pharmaceuticals, Inc. 233.76 -0.24 -0.27 -0.48 7.75 0.47 
(6.46%)		 3.92 -0.40 
(-9.26%)		 3.06 - 7.95 531,411 150,000 51,552
05-05-2022 PM 7:00 AM ET
(May 5)		 AVEO AVEO Pharmaceuticals, Inc. 178.92 -0.30 -0.26 -0.72 AVEO Pharmaceuticals GAAP EPS of -$0.30, revenue of $20.9M
[5/5/2022 7:09 AM]		 4.61 -0.24 
(-4.95%)		 4.75 -0.10 
(-2.06%)		 3.06 - 7.59 289,792 283,280 1,379
14-03-2022 PM Before the open
(Mar 14)		 AVEO AVEO Pharmaceuticals, Inc. 136.12 -0.21 -0.35 -0.44 AVEO Pharmaceuticals GAAP EPS of -$0.21 beats by $0.07, revenue of $17.65M misses by $0.7M
[3/14/2022 7:01 AM]		 4.63 0.85 
(22.49%)		 4.00 0.22 
(5.82%)		 3.06 - 12.79 1,269,632 327,190 14,254
08-11-2021 AH 4:05 PM ET
(Nov 8)		 AVEO AVEO Pharmaceuticals, Inc. 251.27 -0.30 -0.36 -0.33 AVEO Pharmaceuticals EPS beats by $0.06, beats on revenue
[11/8/2021 4:33 PM]		 7.21 -0.12 
(-1.64%)		 7.25 -0.08 
(-1.09%)		 4.95 - 18.24 383,593 250,000 1,034
05-08-2021 AH 4:05 PM ET
(Aug 5)		 AVEO AVEO Pharmaceuticals, Inc. 179.36 -0.48 -0.47 -0.42 AVEO Pharmaceuticals EPS beats by $0.10, beats on revenue
[8/5/2021 5:25 PM]		 5.92 0.42 
(7.64%)		 5.40 -0.10 
(-1.82%)		 4.25 - 18.24 1,213,853 300,000 22,857
10-05-2021 AH 4:05 PM ET
(May 10)		 AVEO AVEO Pharmaceuticals, Inc. 227.81 -0.72 -0.55 -0.52 AVEO Pharmaceuticals EPS misses by $0.26, beats on revenue
[5/10/2021 4:17 PM]		 6.63 0.35 
(5.57%)		 6.03 -0.25 
(-3.98%)		 4.07 - 18.24 1,131,144 660,000 6,133
16-03-2021 AH AVEO AVEO Pharmaceuticals, Inc. 341.97 -0.44 -0.40 -0.28 AVEO Pharmaceuticals EPS misses by $0.06, misses on revenue
[3/16/2021 4:51 PM]		 11.14 -0.26 
(-2.32%)		 10.75 -0.66 
(-5.78%)		 2.23 - 18.24 2,863,792 11,108,176 100,731
09-11-2020 AH AVEO AVEO Pharmaceuticals, Inc. 150.46 -0.33 -0.24 1.00 AVEO Pharmaceuticals EPS misses by $0.10, beats on revenue
[11/9/2020 4:45 PM]		 5.85 -0.17 
(-2.85%)		 5.85 -0.17 
(-2.82%)		 2.23 - 10.71 265,780 210,401 2,148